The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pazopanib vs pazopanib + gemcitabine in refractory soft tissue sarcoma: A randomized phase II trial of the AIO.
 
Hans-Joachim Schmoll
Consulting or Advisory Role - Bayer; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; Roche
 
Jörn Rüssel
No Relationships to Disclose
 
Peter Reichardt
Honoraria - Amgen; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Amgen; ARIAD; Bayer; GlaxoSmithKline; Pfizer; PharmaMar
Research Funding - Novartis (Inst)
 
Lars Lindner
No Relationships to Disclose
 
Hans-Georg Kopp
No Relationships to Disclose
 
Alexander Stein
Speakers' Bureau - Bayer; Celgene; Lilly; Roche; Sanofi
Research Funding - Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche
 
Franziska Cygon
No Relationships to Disclose
 
Klaus Heissner
No Relationships to Disclose